Knowledge and acceptance of human papillomavirus vaccination: perspectives of young Australians living in Melbourne, Australia
Amy McClelland A and Pranee Liamputtong A BA School of Public Health, La Trobe University, Bundoora, Victoria 3086, Australia.
B Corresponding author. Email: pranee@latrobe.edu.au
Sexual Health 3(2) 95-101 https://doi.org/10.1071/SH05035
Submitted: 15 June 2005 Accepted: 24 February 2006 Published: 26 May 2006
Abstract
Background: This paper explores knowledge of and attitudes toward sexually transmissible infections, human papillomavirus (HPV) vaccination and vaccine acceptability among young people in Australia. It also explores factors influencing acceptance and attempts to identify gender differences in knowledge and acceptance. Methods: The study employed a qualitative approach and involved 14 in-depth interviews with young men and women aged between 18 and 23 years who reside in Melbourne, Australia. Results: The findings suggest that knowledge of HPV is inadequate; however, this was not found to have any impact on vaccine acceptance, which was reported as high. No clear gender differences were found in virus and vaccine knowledge and vaccine acceptance. Conclusion: It is clear in the present study that vaccination is generally viewed positively by the young men and women involved in the study and the health beliefs of these individuals have been shaped largely by several factors including cost of the vaccine, access to the vaccine and personal susceptibility to the virus.
Acknowledgements
We wish to thank all the young men and women who participated in the study for their time and their honesty and openness in discussing a sensitive topic.
[1]
[2] Manhart L, Koutsky L. Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 2002; 29(11): 725–35.
| PubMed |
[3] Koutsky L, Ault K, Wheeler C, Brown D, Barr E, Alvarez F, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347(21): 1645–51.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[4] Pinto L., Edwards J., Castle P., Harro C., Lowy D., Schiller J., Wallace D., Kopp W., Adelsberger J., Berzofsky J., Hildesheim A.. Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 virus-like particles. Journal of Infectious Diseases 2003; 188(2): 327.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[5] Boehner C, Howe S, Bernstein D, Rosenthal S. Viral sexually transmitted disease vaccine acceptability among college students. Sex Transm Dis 2003; 30(10): 774–8.
| PubMed |
[6] Hoover D, Carfioli B, Moench E. Attitudes of adolescent/young adult women toward human papillomavirus vaccination and clinical trials. Health Care Women Int 2000; 21(5): 375–91.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[7] Kahn J, Rosenthal S, Hamann T, Bernstein D. Attitudes about human papillomavirus vaccination in young women. Int J STD AIDS 2003; 14(5): 300–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[8] Mays R, Zimet G, Winston Y, Kee R, Dickes J, Su L. Human papillomavirus, genital warts, pap smears, and cervical cancer: knowledge and beliefs of adolescent and adult women. Health Care Women Int 2000a; 21(5): 361–74.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[9] Zimet G, Mays R, Winston Y, Kee R, Dickes J, Su L. Acceptability of human papillomavirus immunization. J Womens Health Gend Based Med 2000b; 9(1): 47–50.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[10] Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papillomavirus among women attending a well woman clinic. Sex Transm Infect 2003; 79 320–2.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[11] Philips Z, Johnson S, Avis M, Whynes DK. Human papillomavirus and the value of screening: Young women’s knowledge of cervical cancer. Health Educ Res 2003; 18(3): 318–28.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[12] Garcia-Carranca A. Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer. Salud Publica Mex 2003; 45(3): 437–42.
[13] Fernbach M. Young women’s issues associated with pap tests: A qualitative study of Victorian women. Health Promot J Aust 2001; 12(3): 254–7.
[14] Smith AMA, Rissel CE, Richters J, Grulich AE, de Visser RO. Sex in Australia: Reproductive experiences and reproductive health among a representative sample of women. Aust N Z J Public Health 2003; 27(2): 204–9.
| PubMed |
[15] Kavanagh AM, Broom DH. Women’s understanding of abnormal cervical smear test results: a qualitative interview study. BMJ 1997; 314 1388–91.
| PubMed |
[16]
[17] Beatty B, O’Connell M, Ashikaga T, Cooper K. Human papillomavirus (HPV) education in middle and high schools in Vermont. J Sch Health 2003; 73(7): 253.
| PubMed |
[18] Martinello R, Jones L, Topal J. Correlation between healthcare workers’ knowledge of influenza vaccine and vaccine receipt. Infect Control Hosp Epidemiol 2003; 24(11): 845.
| PubMed |
[19] Ganguly R, Marty P, Herold A, Anderson M. Hepatitis B immunization in a university student population. J Am Coll Health 1998; 46(4): 181–3.
| PubMed |
[20] Lowy D, Frazer I. Prophylactic human papillomavirus vaccines. J Natl Cancer Inst Monogr 2003; 31 111–6.
| PubMed |
[21] Villa L. Vaccines against human papillomavirus infections and disease. Salud Publica Mex 2003; 45(3): 443–8.
[22]
[23]
[24]
